Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ARG1 | P05089 | 1/20 | 0.30 |
| ▸ | ARG2 | P78540 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL1204724 | 0.96 | MEN1 (0.44) | MEN1LMNAKMT2ATSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL6660435 | 0.96 | MEN1 (0.44) | MEN1LMNAKMT2ATSHRALDH1A1 | |
| Bromide SCHEMBL15820403 | 0.96 | MEN1 (0.44) | MEN1LMNAKMT2ATSHRALDH1A1 | |
| Tromethamine SCHEMBL1933899 | 0.89 | MEN1 (0.67) | MEN1LMNAKMT2A | |
| SCHEMBL14481581 | 0.87 | LMNA (0.37) | MEN1LMNAKMT2ATSHRALDH1A1 | |
| SCHEMBL5056997 | 0.87 | LMNA (0.37) | MEN1LMNAKMT2ATSHRALDH1A1 | |
| SCHEMBL2351528 | 0.87 | MEN1 (0.37) | MEN1LMNAKMT2A | |
| Bicarbonate SCHEMBL8995795 | 0.87 | ARG2 (0.39) | MEN1LMNAKMT2AALDH1A1ARG1 | |
| SCHEMBL818369 | 0.87 | ALDH1A1 (0.41) | MEN1LMNAKMT2ATSHRALDH1A1 | |
| SCHEMBL1686256 | 0.87 | LMNA (0.37) | MEN1LMNAKMT2ATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1022 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4048751-B1 | POLISHING COMPOSITION AND METHOD WITH HIGH SELECTIVITY FOR SILICON NITRIDE AND POLYSILICON OVER SILICON OXIDE | CMC MAT LLC (US) | 2025-03-19 | — | — | EP | claimed |
| EP-4271719-B1 | AQUEOUS COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-11-27 | — | — | EP | claimed |
| US-20240156808-A1 | Compositions and methods to improve the therapeutic benefit of suboptimally chemical compounds and biological therapies including substituted camptothecins such as irinotecan and topotecan for the treatment of benign and neoplastic hyperproliferative disease conditions, infections, inflammatory and immunological diseases | EDISON ONCOLOGY (US) | 2024-05-16 | — | — | US | claimed |
| EP-3574079-B1 | STABLE UNIT DOSE COMPOSITIONS WITH HIGH WATER CONTENT AND STRUCTURED SURFACTANTS | HENKEL AG & CO KGAA (DE) | 2024-05-01 | — | — | EP | claimed |
| EP-3481787-B1 | HALOGEN-FREE QUATERNARY AMINIES AND USES THEREOF | HUNTSMAN PETROCHEMICAL LLC (US) | 2024-02-28 | — | — | EP | claimed |
| US-11905491-B2 | Post CMP cleaning compositions | ENTEGRIS, INC. (US) | 2024-02-20 | — | — | US | claimed |
| EP-3935119-B1 | DRY ELECTRODE ADHESIVE | HENKEL AG & CO KGAA (DE) | 2024-01-24 | — | — | EP | claimed |
| US-20240018369-A1 | AQUEOUS COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC | 2024-01-18 | — | — | US | claimed |
| EP-4034605-B1 | POLISHING COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM ELECTRONIC MAT USA INC (US) | 2024-01-17 | — | — | EP | claimed |
| EP-4045226-B1 | POLISHING COMPOSITIONS AND METHODS OF USE THEREOF | FUJIFILM ELECTRONIC MAT USA INC (US) | 2024-01-03 | — | — | EP | claimed |
| EP-0763132-B1 | ASSAY FOR ENZYME ACTIVITY USING A MICROFLUOROMETRIC ASSAY | ISOLAB INC (US) | 2001-01-24 | — | — | EP | claimed |
| US-5719035-A | MEASURING FLUORESCENT ENZYME PRODUCT | ISOLAB, INC. (US) | 1998-02-17 | — | — | US | claimed |
| EP-0763132-A4 | ASSAY FOR ENZYME ACTIVITY USING A MICROFLUOROMETRIC ASSAY | ISOLAB INC (US) | 1997-06-18 | — | — | EP | claimed |
| EP-0763132-A1 | ASSAY FOR ENZYME ACTIVITY USING A MICROFLUOROMETRIC ASSAY | ISOLAB, INC. (US) | 1997-03-19 | — | — | EP | claimed |
| US-5538857-A | FLUORESCENCE | ISOLAB, INC. (US) | 1996-07-23 | — | — | US | claimed |
| WO-1995033072-A1 | ASSAY FOR ENZYME ACTIVITY USING A MICROFLUOROMETRIC ASSAY | ISOLAB, INC. (US) | 1995-12-07 | — | — | WO | claimed |
| EP-0621772-A1 | HAIR FIXER. | WELLA AG (DE) | 1994-11-02 | — | — | EP | claimed |
| WO-1994012147-A1 | HAIR FIXER | WELLA AKTIENGESELLSCHAFT (DE) | 1994-06-09 | — | — | WO | claimed |
| EP-0375225-A2 | Palladium alloy plating process | AT&T Corp. (US) | 1990-06-27 | — | — | EP | claimed |
| US-4911798-A | Palladium alloy plating process | AT&T BELL LABORATORIES (US) | 1990-03-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240156808-A1 | Compositions and methods to improve the therapeutic benefit of suboptimally chemical compounds and biological therapies including substituted camptothecins such as irinotecan and topotecan for the treatment of benign and neoplastic hyperproliferative disease conditions, infections, inflammatory and immunological diseases | TOP2A, TOP2B, TOP1 | MEN1 601/4885LMNA 1413/4885KMT2A 1727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.